These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8075592)

  • 41. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+).
    Weimar IS; Miranda N; Muller EJ; Hekman A; Kerst JM; de Gast GC; Gerritsen WR
    Exp Hematol; 1998 Aug; 26(9):885-94. PubMed ID: 9694510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanism of transcriptional activation of the immediate early gene Egr-1 in response to PIXY321.
    Mignacca RC; Lee HJ; Kwon EM; Sakamoto KM
    Blood; 1996 Aug; 88(3):848-54. PubMed ID: 8704240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells.
    Bishop MR; Jackson JD; O'Kane-Murphy B; Schmit-Pokorny K; Vose JM; Bierman PJ; Warkentin PI; Armitage JO; Garrison L; Kessinger A
    J Clin Oncol; 1996 Sep; 14(9):2521-6. PubMed ID: 8823331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of multipotential haemopoietic stem cells to neutrophils is associated with increased expression of receptors for granulocyte macrophage colony-stimulating factor: altered biological responses to GM-CSF during development.
    Heyworth CM; Hampson J; Dexter TM; Walker F; Burgess AW; Kan O; Cook N; Vallance SJ; Whetton AD
    Growth Factors; 1991; 5(2):87-98. PubMed ID: 1837466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling.
    Broughton SE; Dhagat U; Hercus TR; Nero TL; Grimbaldeston MA; Bonder CS; Lopez AF; Parker MW
    Immunol Rev; 2012 Nov; 250(1):277-302. PubMed ID: 23046136
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein.
    Curtis BM; Williams DE; Broxmeyer HE; Dunn J; Farrah T; Jeffery E; Clevenger W; deRoos P; Martin U; Friend D
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5809-13. PubMed ID: 1829529
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of the GM-CSF/IL-3 fusion protein PIXY321 on bone marrow and circulating haemopoietic cells of previously untreated patients with cancer.
    Gheilmini M; Pettengell R; Coutinho LH; Testa N; Crowther D
    Br J Haematol; 1996 Apr; 93(1):6-12. PubMed ID: 8611477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Colony-stimulating factor].
    Takaku F
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1216-23. PubMed ID: 3107475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Future uses of granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Jones TC
    Stem Cells; 1994; 12 Suppl 1():229-39; discussion 239-40. PubMed ID: 7696962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Haemopoietic progenitor and myeloid cell kinetics in humans treated with interleukin-3 and granulocyte/macrophage colony-stimulating factor in combination.
    Lord BI; Testa NG; Bretti S; Chang J; Demuynck H; Coutinho L; de Campos E; Fitzsimmons L; Scarffe JH
    Int J Cancer; 1994 Nov; 59(4):483-90. PubMed ID: 7960217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Biology and clinical applications of GM-CSF].
    Robak T
    Acta Haematol Pol; 1994; 25(2):99-109. PubMed ID: 8067193
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful stimulation of autologous bone marrow recovery by GM-CSF and IL-3 after an unrelated donor BMT for juvenile CML complicated by graft failure.
    Suttorp M; Schmitz N; Prange E; Ganser A; Löffler H; Schaub J
    Bone Marrow Transplant; 1991; 7 Suppl 2():84. PubMed ID: 1878734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of human granulocyte-macrophage colony stimulating factor/interleukin-3 fusion protein (PIXY321) on the hematopoietic toxicity associated with anti-viral drugs (zidovudine and didanosine) in vitro using normal human marrow cells.
    Gallicchio VS; Hughes NK
    Life Sci; 1995; 57(18):PL265-73. PubMed ID: 7475901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of benzene metabolites on differentiation of bone marrow progenitor cells.
    Irons RD; Stillman WS
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1247-50. PubMed ID: 9118900
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Interleukin-3: a preclinical study].
    Valent P; Geissler K; Bettelheim P
    Wien Klin Wochenschr; 1989 Oct; 101(19):652-63. PubMed ID: 2482586
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical applications of hematopoietic growth factors.
    Vose JM; Armitage JO
    J Clin Oncol; 1995 Apr; 13(4):1023-35. PubMed ID: 7535842
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transforming growth factor-beta trans-modulates the expression of colony stimulating factor receptors on murine hematopoietic progenitor cell lines.
    Jacobsen SE; Ruscetti FW; Dubois CM; Lee J; Boone TC; Keller JR
    Blood; 1991 Apr; 77(8):1706-16. PubMed ID: 1707695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early suppressive effects of chemotherapy and cytokine treatment on committed versus primitive haemopoietic progenitors in patient bone marrow.
    Schwartz GN; Hakim F; Zujewski J; Szabo JM; Cepada R; Riseberg D; Warren MK; Mackall CL; Setzer A; Noone M; Cowan KH; O'Shaughnessy J; Gress RE
    Br J Haematol; 1996 Mar; 92(3):537-47. PubMed ID: 8616014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phase I/II trial of PIXY321 to enhance engraftment following autologous bone marrow transplantation for lymphoid malignancy.
    Vose JM; Anderson JE; Bierman PJ; Appelbaum FR; Anderson JR; Garrison L; Lebsack ME; Armitage JO
    J Clin Oncol; 1996 Feb; 14(2):520-6. PubMed ID: 8636766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential effects of sequential, simultaneous, and single agent interleukin-3 and granulocyte-macrophage colony-stimulating factor on megakaryocyte maturation and platelet response in primates.
    Stahl CP; Winton EF; Monroe MC; Haff E; Holman RC; Myers L; Liehl E; Evatt BL
    Blood; 1992 Nov; 80(10):2479-85. PubMed ID: 1421371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.